Literature DB >> 15985368

Bilateral atypical ductal hyperplasia, an incidental finding in gynaecomastia--case report and literature review.

Vani Prasad1, John M King, William McLeay, Wendy Raymond, Rodney D Cooter.   

Abstract

Male breast cancer is a rare disease. Atypical ductal hyperplasia (ADH) in men is much rarer, and bilateral involvement is exceptional. A 20-year-old male presented with bilateral gynaecomastia who underwent subcutaneous mastectomies and histopathology revealed bilateral ADH. At 24 months, completion mastectomies were performed on both sides. The residual breast tissue revealed ADH similar to the initial specimen. ADH in women increases the risk of breast cancer by four to five times. To our knowledge, this is the first case report of bilateral ADH in a gynaecomastia specimen.

Entities:  

Mesh:

Year:  2005        PMID: 15985368     DOI: 10.1016/j.breast.2005.04.010

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  4 in total

Review 1.  Is routine pathological evaluation of tissue from gynecomastia necessary? A 15-year retrospective pathological and literature review.

Authors:  Jenna-Lynn Senger; Geethan Chandran; Rani Kanthan
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

2.  Surgical management of gynecomastia--a 10-year analysis.

Authors:  A E Handschin; D Bietry; R Hüsler; A Banic; M Constantinescu
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

3.  Radiologic and Pathologic Findings of Atypical Ductal Hyperplasia in the Male Breast: Case Report and Literature Review.

Authors:  Ara Ko; Hye Shin Ahn; Seungho Lee; Su Min Ha; Min Kyoon Kim; Hee Sung Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-09-25

Review 4.  Male breast cancer: is the scenario changing.

Authors:  Kaiyumars B Contractor; Kanchan Kaur; Gabriel S Rodrigues; Dhananjay M Kulkarni; Hemant Singhal
Journal:  World J Surg Oncol       Date:  2008-06-16       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.